Guardant DNA blood test finds 83% of colorectal cancers in trial, shares fall 35%
By Deena Beasley (Reuters) -Guardant Health Inc said on Thursday a pivotal trial of its DNA blood test showed it detected 83% of colorectal cancers and 13% of advanced adenomas,…